Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-14315

Single-particle
3.9 Å
EMD-14315
3D View Gallery
Deposition: 09/02/2022
Map released: 08/06/2022
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-14315
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 7r4r summary report (pdf.gz) Map and 7r4r FULL report (pdf.gz)
EMICSS annotations (xml)

The SARS-CoV-2 spike in complex with the 1.10 neutralizing nanobody

EMD-14315

Single-particle
3.9 Å
EMD-14315
3D View Gallery
Deposition: 09/02/2022
Map released: 08/06/2022
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Camelus dromedarius
Sample: The trimeric SARS-CooV-2 spike in complex with the 1.10 neutralizing nanobody
Fitted models: 7r4r

Deposition Authors: Casasnovas JM, Melero R
Nanobodies Protecting From Lethal SARS-CoV-2 Infection Target Receptor Binding Epitopes Preserved in Virus Variants Other Than Omicron.
Casasnovas JM, Margolles Y , Noriega MA, Guzman M, Arranz R, Melero R, Casanova M, Corbera JA , Jimenez-de-Oya N , Gastaminza P, Garaigorta U , Saiz JC, Martin-Acebes MA, Fernandez LA
(2022) Front Immunol , 13 , 863831 - 863831
PUBMED: 35547740
DOI: doi:10.3389/fimmu.2022.863831
ISSN: 1664-3224